Adenoviral vectors of canine origin

Number of patents in Portfolio can not be more than 2000

United States of America

SERIAL NO

08553317

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

PCT No. PCT/FR94/00531 Sec. 371 Date Nov. 29, 1995 Sec. 102(e) Date Nov. 29, 1995 PCT Filed May 6, 1994 PCT Pub. No. WO94/26914 PCT Pub. Date Nov. 24, 1994The present invention resides in use of a recombinant adenovirus of animal origin containing a heterologous DNA sequence for the preparation of a pharmaceutical composition intended for the therapeutic and/or surgical treatment of the human body.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • RHONE-POULENC RORER S.A.

International Classification(s)

  • No Non-US Classification to display

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
HADDADA, HEDI FR 5 55
KLONJKOWSKI, BERNARD FR 2 25
PERRICAUDET, MICHEL FR 60 654
VIGNE, EMMANUELLE FR 23 325

Cited Art Landscape

Load Citation

Patent Citation Ranking

  • Citation Ranking not provided

Forward Cite Landscape

Load Citation